Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients

Rheumatology

Volumn 42, Issue 8, 2003, Pages 939-946

  Vittecoq, Olivier ^a,b   Pouplin, S ^b   Krzanowska, K ^b   Jouen Beades, F ^a   Menard J F ^b   Gayet, A ^c   Daragon, A ^a,b   Tron, F ^a   Le Loet X ^a,b  

^a INSERM   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c Coll Rhumatologues Haute Normandie ^*  (France)

Author keywords

Autoantibodies; Community based population; Prognosis; Radiological progression; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

ANTIRHEUMATIC AGENT; AUTOANTIBODY; C REACTIVE PROTEIN; CALPASTATIN; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; FILAGGRIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KERATIN ANTIBODY; LIPOCORTIN 5; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BONE DESTRUCTION; CLINICAL FEATURE; COMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HAND RADIOGRAPHY; HUMAN; IMMUNOFLUORESCENCE TEST; JOINT CAVITY; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; AUTOANTIBODIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN M; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RHEUMATOID FACTOR; STATISTICS, NONPARAMETRIC;

EID: 0141839077     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg257     Document Type: Article

References (49)

1. Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995;54:944-7.
2. van der Heijde DMFM, van Riel PLCM, van Rijswijk MH, van de Putte LB. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 1988;17:284-92.
3. Jönsson T, Thorsteinsson J, Kolbeinsson A, Jönasdöttir E, Sigfüsson N, Valdimarsson H. Population study of the importance of rheumatoid factor isotypes in adults. Ann Rheum Dis 1992;51:863-8.
4. Jönsson T, Arinbjarnarson S, Thorsteinsson J et al. Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 1995;24:372-5.
5. Houssien DA, Jonsson T, Davies E, Scott DL. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis: comparative effects of different antigens. Scand J Rheumatol 1998;27:46-53.
6. Caruso I, Santandrea S, Puttini P et al. Clinical, laboratory and radiographic features in early rheumatoid arthritis. J Rheumatol 1990;17:1263-7.
7. van Schaardenburg D, Hazes JMW, de Boer A, Zwinderman AH, Meijers KAE, Breedveld FC. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993;20:45-52.
8. Naka T, Kondo M, Mashima T. Clinical significance of IgG rheumatoid factor in patients with rheumatoid arthritis. Ryumachi 1995;35:530-7.
9. Aho K, Palosuo T, Matti L et al. Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol 1999; 28:113-6.
10. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 1992; 51:743-6.
11. Westgeest AAA, Boerbooms AMT, Jongmans M, Vandenbroucke JP, Vierwinden G, van de Putte LBA. Antiperinuclear factor: indication of more severe disease in seronegative rheumatoid arthritis. J Rheumatol 1987; 14:893-7.
12. Hayem G, Chazerain P, Combe B et al. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol 1999;26:7-13.
13. Boire G, Ménard HA. Clinical significance of anti-Ro/SSA antibody in rheumatoid arthritis. J Rheumatol 1988; 15:391-4.
14. Coremans IEM, Hagen EC, Daha MR et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466-75.
15. Hayem G, De Bandt M, Palazzo E et al. Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis 1999;58:291-6.
16. Harrison B, Thomson W, Symmons D et al. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum 1999;42:2174-83.
17. Gough A, Faint A, Salmon M et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994; 37:1166-70.
18. Valenzuela-Castano A, Garcia-Lopez A, Perez-Vilches D, Rodriguez-Perez R, Gonzalez-Escribano MF, Nunez-Roldan A. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study. J Rheumatol 2000;27:571-4.
19. van der Heijde DMFM. The continuing challenge of predictive factors in rheumatoid arthritis: prediction or association? J Rheumatol 1997;24:6-8.
20. Brook A, Corbett M. Radiographic change in early rheumatoid disease. Ann Rheum Dis 1977;36:71-3.
21. Mottönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648-53.
22. Paimela L, Palosuo T, Leirisalo-Repo M et al. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis. Br J Rheumatol 1995; 34:1146-50.
23. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
24. van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, van Thof MA, van Rijswijk MH, van de Putte LBAI. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up of 147 patients. Br J Rheumatol 1992; 31:519-25.
25. van Zeben D, Hazes JMW, Zwinderman AH, Vandenbroucke JP, Breedveld D. Factors predicting outcome of rheumatoid arthritis: results of a follow-up study. J Rheumatol 1993;20:1288-96.
26. van der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijcsma JWJ. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
27. van Leeuwen MA, Westra J, van Riel PLCM, Limburg PC, van Rijswijk MH. IgM, IgA and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 1995;24:146-53.
28. Eberhardt KB, Svensson B, Truedsson L, Wollheim A. The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis - no relationship with erosions or disease activity. J Rheumatol 1988;15:1070-4.
29. Mottönen TT, Paimela L, Leirisalo-Repo M, Kautiainen H, Llonen J, Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with 'sawtooth' strategy. Ann Rheum Dis 1998;57:533-9.
30. Pease CT, Bhakta BB, Devlin J, Emery P. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology 1999;38:228-43.
31. Uhlig T, Smedstad LM, Vaglum P, Moum T, Gerard N, Kvien TK. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology 2000;39:732-41.
32. Kroot EJA, de Jong BAW, van Leeuwen MA et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5.
33. Mustila A, Paimela L, Leirisalo-Repo M, Huhtala H, Miettinen A. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis. An early marker of progressive erosive disease. Arthritis Rheum 2000; 43:1371-7.
34. Combe B, Dougados M, Goupille P et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum 2001;44:1736-43.
35. Bukhari M, Lunt M, Harrisson BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002; 46:906-12.
36. Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BA. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:924-7.
37. Vittecoq O, Jouen-Beades F, Krzanowska K et al. Prospective evaluation of the frequency and clinical significance of anti-neutrophil cytoplasmic and anti-cardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology 2000;39:481-9.
38. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
39. Girard F, Guillemin F, Novella JL et al. Health-care use by rheumatoid arthritis patients compared with non-arthritic subjects. Rheumatology 2002;41:167-75.
40. van der Heijde DMFM, van Riel PLCM, Nuver-Zwart IH, Gribnau FW, van de Putte LBA. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;13:1036-8.
41. Pouchot J, Guillemin F, Coste J. Mesures de qualité de vie en rhumatologie. Presse Med 1994;23:1328-30.
42. Vittecoq O, Jouen-Beades F, Krzanowska K et al. Rheumatoid factors, anti-filaggrin antibodies, and low in vitro interleukin 2 and interferon γ production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis. Preliminary study. Joint Bone Spine 2001;68:144-53.
43. Vittecoq O, Inçaurgarat B, Legoedec J et al. High diagnostic value of anti-filaggrin autoantibodies (AFA) detected by a new ELISA using citrullinated and non-citrullinated recombinant proteins as antigens in a cohort of 152 community cases of very early arthritis [abstract]. Ann Rheum Dis 2001;60:S128.
44. Vittecoq O, Salle V, Jouen-Beades F et al. Autoantibodies to the 27 C-terminal amino-acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis. Rheumatology 2001;40:1126-34.
45. Jonsson T, Steisson K, Jonsson H, Geirsson AJ, Thorsteinsson J, Valdimarsson H. Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis. Rheumatol Int 1998; 18:119-22.
46. Salle V, Vittecoq O, Jouen-Beades F et al. High levels of autoantibodies directed against the domain I of calpastatin are related to vasculitis in systemic lupus erythematosus [abstract]. Arthritis Rheum 2000;43:S254.
47. Graudal NA, Jurik AG, de Carvalho A, Graudal HK. Radiographic progression in rheumatoid arthritis. A long term prospective study of 109 patients. Arthritis Rheum 1998;41:1470-80.
48. Vittecoq O, Jouen-Beades F, Delpech A, Gilbert D, Tron F, Le Loët X. Autoantibodies in rheumatoid arthritis. Rev Rhum Fr Ed 1995;62:195S-200S.
49. Hanly JG, Hassan J, Whelan A, Feighery C, Bresnihan B. Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients. Arthritis Rheum 1986;29:480-7.